David D. O'toole net worth and biography

David O'toole Biography and Net Worth

CFO of Avita Medical

An accomplished financial executive with extensive experience in both public company operations and capital markets, Mr. O’Toole joined AVITA Medical in 2023 as its Chief Financial Officer. Mr. O’Toole most recently served as CFO of Opiant Pharmaceuticals, a biopharmaceutical company developing treatments for addiction and drug overdose, which was acquired by Indivior in March of 2023. Prior to that, he served as CFO of Soleno Therapeutics, a company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Prior to Soleno, Mr. O’Toole held the role of CFO for three publicly traded life sciences companies where he built and led high-performance teams. Prior to his CFO experience, he spent over 20 years in public accounting, including 16 years with Deloitte & Touche. He holds a Bachelor of Science in accounting from the University of Arizona and is a Certified Public Accountant (non-active).

What is David D. O'toole's net worth?: The estimated net worth of David D. O'toole is at least $1.15 million as of May 19th, 2026. O'toole owns 145,927 shares of Avita Medical stock worth more than $1,146,111 as of August 10th. This net worth evaluation does not reflect any other investments that O'toole may own. Learn More about David D. O'toole's net worth.
How do I contact David D. O'toole?: The corporate mailing address for O'toole and other Avita Medical executives is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. Avita Medical can also be reached via phone at (833) 462-8482 and via email at [email protected]. Learn More on David D. O'toole's contact information.
Has David D. O'toole been buying or selling shares of Avita Medical?: David D. O'toole has not been actively trading shares of Avita Medical within the last three months. Most recently, on Tuesday, May 19th, David D. O'toole bought 2,000 shares of Avita Medical stock. The stock was acquired at an average cost of $4.24 per share, with a total value of $8,480.00. Following the completion of the transaction, the chief financial officer now directly owns 145,927 shares of the company's stock, valued at $618,730.48. Learn More on David D. O'toole's trading history.
Who are Avita Medical's active insiders?: Avita Medical's insider roster includes Suzanne Crowe (Director), Robert McNamara (Director), David O'toole (CFO), David O'Toole (CFO), Michael Perry (CEO), and Joseph Woody (Director). Learn More on Avita Medical's active insiders.
Are insiders buying or selling shares of Avita Medical?: In the last year, Avita Medical insiders bought shares 10 times. They purchased a total of 64,200 shares worth more than $281,190.00. The most recent insider tranaction occured on June, 9th when Director Joseph Fralin Woody bought 10,000 shares worth more than $41,900.00. Insiders at Avita Medical own 2.2% of the company. Learn More about insider trades at Avita Medical.
Information on this page was last updated on 6/9/2026.

David D. O'toole Insider Trading History at Avita Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/19/2026	Buy	2,000	$4.24	$8,480.00	145,927
2/19/2026	Buy	3,000	$4.15	$12,450.00	140,127
8/26/2025	Buy	2,000	$4.52	$9,040.00	31,657
8/12/2025	Buy	2,000	$4.81	$9,620.00	29,657
2/19/2025	Buy	1,000	$10.25	$10,250.00	24,734
12/5/2024	Buy	975	$12.46	$12,148.50	23,734
5/30/2024	Buy	1,000	$8.90	$8,900.00	19,734
12/12/2023	Buy	950	$12.45	$11,827.50	17,484
12/1/2023	Buy	500	$10.68	$5,340.00	16,534
11/16/2023	Buy	1,000	$12.15	$12,150.00	12,000
11/14/2023	Buy	1,000	$12.88	$12,880.00	10,000
8/15/2023	Buy	5,000	$17.93	$89,650.00	7,000
6/20/2023	Buy	1,000	$16.15	$16,150.00	2,000

David D. O'toole Buying and Selling Activity at Avita Medical

Avita Medical Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Today's Range

Now: $7.85

$7.39

$8.35

50 Day Range

MA: $4.47

$3.91

$7.77

2 Week Range

Now: $7.85

$3.22

$8.35

Volume

575,447 shs

Average Volume

302,917 shs

Market Capitalization

$241.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86